Gladys Ho

Gladys Ho is a Senior Lecturer at the Children's Hospital Westmead Clinical School, University of Sydney, with extensive contributions to genomic medicine and pediatric genetics. Her work spans multiple clinical and research domains with a focus on translating genomic discoveries into clinical practice across various medical specialties including neurology, pulmonology, and metabolic medicine.

Dr. Ho's research interests center on genomic applications in clinical settings, particularly newborn genomic screening, diagnostics of rare genetic disorders, and the implementation of genomic medicine in healthcare systems. Her work demonstrates strong interdisciplinary collaboration across medical specialties, with significant focus on inborn errors of metabolism, pediatric neurological disorders, and the clinical utility of genomic technologies. She has contributed to major national initiatives including the Australian Reproductive Genetic Carrier Screening Project (Mackenzie's Mission) and the Genomic Screening Consortium for Australian Newborns (GenSCAN).

Analysis of her recent publications (2022-2025) reveals a strong emphasis on implementing genomic technologies in clinical practice, with particular attention to diagnostic accuracy, validation processes, and clinical utility across multiple medical specialties. Her work spans neurogenetics, metabolic disorders, pulmonary conditions, and cancer genetics, demonstrating the broad applicability of genomic medicine. A recurring theme is the translation of genomic discoveries into practical clinical applications, with several papers addressing implementation challenges and healthcare system integration.

Dr. Ho is actively involved in significant research funding initiatives, most notably as a co-investigator on the 2022 Department of Health and Aged Care grant titled 'NEWBORN GENomicSEQuencing in screening: TherapyReadyAndInformation forLife' under the Genomics Health Futures Mission. This project represents a major national effort to incorporate genomic sequencing into newborn screening programs, with potential to transform early diagnosis and intervention for genetic conditions.

Her collaborative research approach is evident across multiple clinical settings, working with interdisciplinary teams to address complex diagnostic challenges in rare diseases. Dr. Ho's work bridges laboratory research and clinical application, with particular emphasis on validating genomic findings and ensuring their appropriate clinical interpretation.